天然他类药物和中风风险

Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.

The Journal of clinical endocrinology and metabolism·2012

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Journal of internal medicine·2006

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.

European heart journal·2002

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Annals of internal medicine·2001

Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.

Annals of epidemiology·2001

Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile.

Circulation·2001

Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives.

Circulation·2026

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Circulation·2026

Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association.

Circulation·2026

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.

Circulation·2026

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026

Discovery of Anti-Japanese Encephalitis Compounds: Based on Natural Compound Library, Bioinformatics, Network Pharmacology and Experimental Validation.

Current pharmaceutical design·2026

Steroids from <i>Talaromyces stipitatus</i> as potential hepatocellular carcinoma inhibitors: A computational study.

Molecular biology research communications·2026

AI-driven drug discovery using transformer-based molecular representation learning.

Frontiers in artificial intelligence·2026

Molecular and metabolic dysregulation of lung cancer in developing anti-tumor activity by gambogic acid mediated mTOR signaling: in vitro and computational study.

3 Biotech·2026

The Substitute Groups in FDA-Approved Small Molecule Drugs in 2020 - 2024.

Current medicinal chemistry·2026

Multi-Target Synergy of Coridius chinensis in Testicular Aging via Network Pharmacology-Metabolomics Integration.

Current medicinal chemistry·2026

相关实验视频

天然他类药物和中风风险

相关概念视频

Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.

Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile.

Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives.

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association.

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Discovery of Anti-Japanese Encephalitis Compounds: Based on Natural Compound Library, Bioinformatics, Network Pharmacology and Experimental Validation.

Steroids from <i>Talaromyces stipitatus</i> as potential hepatocellular carcinoma inhibitors: A computational study.

AI-driven drug discovery using transformer-based molecular representation learning.

Molecular and metabolic dysregulation of lung cancer in developing anti-tumor activity by gambogic acid mediated mTOR signaling: in vitro and computational study.

The Substitute Groups in FDA-Approved Small Molecule Drugs in 2020 - 2024.

Multi-Target Synergy of Coridius chinensis in Testicular Aging via Network Pharmacology-Metabolomics Integration.

相关实验视频

天然他类药物和中风风险

相关概念视频

相关文章